| Theme | Reconsidering of Diet Therapy for Patients with Chronic Kidney Disease -- Is the clinical guideline for diet therapy edited by Japanese Society of Nephrology at 1997 valid? | |
|---|---|---|
| Title | Diet therapy for treatment of progressive renal failure due to non-diabetic nephropathy | |
| Publish Date | 2006/12 | |
| Author | Tatsuo Shiigai | Department of Nephrology, Toride Kyodo General Hospital |
| [ Summary ] | The role of diet therapy (DT) in delaying the progression of chronic renal failure remains important. However, the necessity of DT has decreased somewhat since the introduction of renin-angiotensin system blocking therapy (RASBT). Attempts were made to check the effects of DT with the RASBT through a multi-centered, randomized trial. Meanwhile, one school of thought insists that a very low protein diet (VLPD) is only effective in delaying progression of the condition. There is concern over the prevalent use of treatments such as VLPD, because their use presents a great risk of malnutrition. Protein intake in the 0.75 - 0.85 g / st Wt kg level has been seen to be effective in the current literature. If target of protein intake is roughly 0.6 g / st Wt kg, the patient may be at risky, falling into the 0.58 g / st Wt kg category. Therefore, a 0.75 - 0.85 g protein intake is recommended for renal failure patients with non-diabetic kidney disease. |
|